LIS Technologies Inc. Receives a Non-possessing Facility Clearance from the Nuclear Regulatory Commission Paving a Path for Access to Classified Matter

/EIN News/ -- Oak Ridge, Tennessee, March 27, 2025 (GLOBE NEWSWIRE) -- LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of advanced laser technology and the only USA-origin and patented laser uranium enrichment company, today announced that it has received a non-possessing Facility Clearance from the Nuclear Regulatory Commission (NRC). This allows the Company to apply for security clearances for its key employees. The CRISLA technology is a sensitive nuclear technology, and the Company is confident that the DOE will eventually designate the technology as classified restricted data, allowing a path for access to Classified Matter.

Figure 1 - LIS Technologies Inc. Receives a Non-possessing Facility Clearance from the Nuclear Regulatory Commission (NRC) Paving a Path for Access to Classified Matter. This allows the Company to apply for security clearances for its key employees.

“LIS Technologies is positioning itself to become a leader in the production of nuclear fuel for civilian nuclear reactors as well as advanced reactors such as SMRs and microreactors” said Jay Yu, Executive Chairman and President of LIS Technologies Inc. “Obtaining security clearances for key personnel is a major step towards this goal and will enable the Company to accelerate the deployment of our technology.”

"The CRISLA technology shows immense potential, and I believe it is only a matter of time before the DOE Office of Classification requires the technology to be protected," said Christo Liebenberg, CEO of LIS Technologies Inc. "Our proactive approach in obtaining a Facility Clearance and Q-clearances for key personnel will help to position us favorably once the technology becomes Classified. Several design aspects of the CRISLA technology are already being protected as CUI within the Company.”

LIS Technologies is building on the growing momentum within the United States nuclear energy industry, having been selected in December 2024 as one of six companies to participate in the Low-Enriched Uranium (LEU) Enrichment Acquisition Program. This initiative allocates up to $3.4 billion overall, with contracts lasting for up to 10 years. Optimized for both Low-Enriched Uranium (LEU) and High-Assay Low-Enriched Uranium (HALEU), it overcomes the limitations of traditional pulsed 16µm CO₂ lasers, featuring a streamlined design due to its lower absorption and shorter wavelength at 5.3µm. Demonstrated in the 1980s and 90s, this technology is protected by a patent from the United States Patent and Trademark Office (USPTO). Variations of the technology, as well as further development of the baseline technology, is treated by the Company as “Trade Secret” and as such is protected.

About LIS Technologies Inc.

LIS Technologies Inc. (LIST) is a USA based, proprietary developer of a patented advanced laser technology, making use of infrared lasers to selectively excite the molecules of desired isotopes to separate them from other isotopes. The Laser Isotope Separation Technology (L.I.S.T) has a huge range of applications, including being the only USA-origin (and patented) laser uranium enrichment company, and several major advantages over traditional methods such as gas diffusion, centrifuges, and prior art laser enrichment. The LIST proprietary laser-based process is more energy-efficient and has the potential to be deployed with highly competitive capital and operational costs. L.I.S.T is optimized for LEU (Low Enriched Uranium) for existing civilian nuclear power plants, High-Assay LEU (HALEU) for the next generation of Small Modular Reactors (SMR) and Microreactors, the production of stable isotopes for medical and scientific research, and applications in quantum computing manufacturing for semiconductor technologies. The Company employs a world class nuclear technical team working alongside leading nuclear entrepreneurs and industry professionals, possessing strong relationships with government and private nuclear industries.

In Dec 2024, LIS Technologies Inc. was selected as one of six domestic companies to participate in the Low-Enriched Uranium (LEU) Enrichment Acquisition Program. This initiative allocates up to $3.4 billion overall, with contracts lasting for up to 10 years. Each awardee is slated to receive a minimum contract of $2 million.

For more information please visit: LaserIsTech.com

For further information, please contact:
Email: info@laseristech.com
Telephone: 800-388-5492
Follow us on X Platform
Follow us on LinkedIn

Forward Looking Statements

This news release contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects", "anticipates", "intends", "plans", "believes", "will", "should", "could", "would" or "may" and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve known and unknown risks, uncertainties and other factors, which may be beyond our control. For LIS Technologies Inc., particular risks and uncertainties that could cause our actual future results to differ materially from those expressed in our forward-looking statements include but are not limited to the following which are, and will be, exacerbated by any worsening of global business and economic environment: (i) risks related to the development of new or advanced technology, including difficulties with design and testing, cost overruns, development of competitive technology, loss of key individuals and uncertainty of success of patent filing, (ii) our ability to obtain contracts and funding to be able to continue operations and (iii) risks related to uncertainty regarding our ability to commercially deploy a competitive laser enrichment technology, (iv) risks related to the impact of government regulation and policies including by the DOE and the U.S. Nuclear Regulatory Commission; and other risks and uncertainties discussed in this and our other filings with the SEC. Only after successful completion of our Phase 2 Pilot Plant demonstration will LIS Technologies be able to make realistic economic predictions for a Commercial Facility. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. These factors may not constitute all factors that could cause actual results to differ from those discussed in any forward-looking statement. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.

Attachment

• LIS Technologies Inc.